Literature DB >> 21806295

Studies of inactivation of encephalomyocarditis virus, M13 bacteriophage, and Salmonella typhimurium by using a visible femtosecond laser: insight into the possible inactivation mechanisms.

Kong T Tsen1, Shaw-Wei D Tsen, Qiang Fu, Stuart M Lindsay, Zhe Li, Stephanie Cope, Sara Vaiana, Juliann G Kiang.   

Abstract

We report experimental results on the inactivation of encephalomyocarditis virus, M13 bacteriophage, and Salmonella typhimurium by a visible femtosecond laser. Our results suggest that inactivation of virus and bacterium by a visible femtosecond laser involves completely different mechanisms. Inactivation of viruses by a visible femtosecond laser involves the breaking of hydrogen∕hydrophobic bonds or the separation of the weak protein links in the protein shell of a viral particle. In contrast, inactivation of bacteria is related to the damage of their DNAs due to irradiation of a visible femtosecond laser. Possible mechanisms for the inactivation of viruses and bacteria are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21806295     DOI: 10.1117/1.3600771

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  17 in total

1.  Selective photonic disinfection of cell culture using a visible ultrashort pulsed laser.

Authors:  Shaw-Wei D Tsen; Karen Kibler; Bert Jacobs; Justin C Fay; N P Podolnikova; T P Ugarova; Samuel Achilefu; Kong-Thon Tsen
Journal:  IEEE J Sel Top Quantum Electron       Date:  2015-11-09       Impact factor: 4.544

2.  Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment.

Authors:  Shaw-Wei David Tsen; Nisha Donthi; Victor La; Wen-Han Hsieh; Yen-Der Li; Jayne Knoff; Alexander Chen; Tzyy-Choou Wu; Chien-Fu Hung; Samuel Achilefu; Kong-Thon Tsen
Journal:  J Biomed Opt       Date:  2015-05       Impact factor: 3.170

Review 3.  Phototherapy and optical waveguides for the treatment of infection.

Authors:  Dingbowen Wang; Michelle Laurel Kuzma; Xinyu Tan; Tong-Chuan He; Cheng Dong; Zhiwen Liu; Jian Yang
Journal:  Adv Drug Deliv Rev       Date:  2021-11-03       Impact factor: 15.470

4.  Inactivation of multidrug-resistant bacteria and bacterial spores and generation of high-potency bacterial vaccines using ultrashort pulsed lasers.

Authors:  Shaw-Wei David Tsen; John Popovich; Megan Hodges; Shelley E Haydel; Kong-Thon Tsen; Gail Sudlow; Elizabeth A Mueller; Petra Anne Levin; Samuel Achilefu
Journal:  J Biophotonics       Date:  2021-12-08       Impact factor: 3.207

5.  Inactivation of enveloped virus by laser-driven protein aggregation.

Authors:  Shaw-Wei D Tsen; Travis Chapa; Wandy Beatty; Kong-Thon Tsen; Dong Yu; Samuel Achilefu
Journal:  J Biomed Opt       Date:  2012-12       Impact factor: 3.170

6.  Ultrashort pulsed laser treatment inactivates viruses by inhibiting viral replication and transcription in the host nucleus.

Authors:  Shaw-Wei D Tsen; Travis Chapa; Wandy Beatty; Baogang Xu; Kong-Thon Tsen; Samuel Achilefu
Journal:  Antiviral Res       Date:  2014-07-30       Impact factor: 5.970

Review 7.  Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond.

Authors:  Rui Yin; Tianhong Dai; Pinar Avci; Ana Elisa Serafim Jorge; Wanessa C M A de Melo; Daniela Vecchio; Ying-Ying Huang; Asheesh Gupta; Michael R Hamblin
Journal:  Curr Opin Pharmacol       Date:  2013-09-20       Impact factor: 5.547

8.  Prospects for a novel ultrashort pulsed laser technology for pathogen inactivation.

Authors:  Shaw-Wei D Tsen; Tzyy Choou Wu; Juliann G Kiang; Kong-Thon Tsen
Journal:  J Biomed Sci       Date:  2012-07-06       Impact factor: 8.410

Review 9.  The encephalomyocarditis virus.

Authors:  Margot Carocci; Labib Bakkali-Kassimi
Journal:  Virulence       Date:  2012-06-22       Impact factor: 5.882

10.  Studies of inactivation mechanism of non-enveloped icosahedral virus by a visible ultrashort pulsed laser.

Authors:  Shaw-Wei D Tsen; David H Kingsley; Christian Poweleit; Samuel Achilefu; Douglas S Soroka; T C Wu; Kong-Thon Tsen
Journal:  Virol J       Date:  2014-02-05       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.